Are you Dr. O'Connell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
812 Paxton Rd Sw
Rochester, MN 55902Phone+1 507-289-3675
Summary
- Dr. Michael O'Connell, MD is an oncologist in Rochester, Minnesota. He is currently licensed to practice medicine in Minnesota and New Hampshire.
Education & Training
- University of MinnesotaResidency, Internal Medicine, 1969 - 1971
- University of Minnesota Medical SchoolClass of 1969
Certifications & Licensure
- MN State Medical License 1970 - 2016
- NH State Medical License 1987 - 2013
Publications & Presentations
PubMed
- 649 citationsTreatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.Larry K. Kvols, Charles G. Moertel, Michael J. O'Connell, Allan J. Schutt, Joseph Rubin
The New England Journal of Medicine. 1986-09-11 - 44 citationsSex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT DatabaseAnna Dorothea Wagner, Axel Grothey, Thierry André, Jesse G. Dixon, Norman Wolmark
Journal of the National Cancer Institute. 2021-04-06 - 203 citationsNeoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical TrialCarmen J. Allegra, Greg Yothers, Michael O’Connell, Robert W. Beart, Timothy F. Wozniak
Journal of the National Cancer Institute. 2015-11-01
Grant Support
- North Central Cancer Treatment GroupNational Cancer Institute1994–2001
- Clinical Trials ProgramNational Cancer Institute1993–1999
- Cancer Treatment GroupNational Cancer Institute1994–1995
- The North Central Cancer Treatment GroupNational Cancer Institute1993–1995
- Community Clinical Oncology ProgramNational Cancer Institute1993–1995
- Cancer TreatmentNational Cancer Institute1994
- Clinical TrialsNational Cancer Institute1988–1992